Susquehanna International Group, LLP Novo Cure LTD Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Novo Cure LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 187,442 shares of NVCR stock, worth $2.93 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
187,442
Previous 617,663
69.65%
Holding current value
$2.93 Million
Previous $9.65 Million
66.75%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
77.2MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$189 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$183 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$174 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$46.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.38MShares$37.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.64B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...